Search

Search Constraints

You searched for: Date 2017 Author/Creator Toth, Kalman

Search Results

2. Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial. Issue 10106 (28th October 2017)